ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $3.44 billion. The enterprise value is $4.54 billion.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.69 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 24.69M |
| Shares Outstanding | 24.69M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 101.95% |
| Float | 23.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 157.24 |
| PS Ratio | 1.52 |
| Forward PS | 1.59 |
| PB Ratio | 1.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 48.18 |
| P/OCF Ratio | 21.74 |
| PEG Ratio | 14.71 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.68, with an EV/FCF ratio of 63.14.
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | 13.68 |
| EV / EBIT | 35.14 |
| EV / FCF | 63.14 |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.45 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.92 |
| Debt / FCF | 19.18 |
| Interest Coverage | 1.34 |
Financial Efficiency
Return on equity (ROE) is -0.35% and return on invested capital (ROIC) is 2.24%.
| Return on Equity (ROE) | -0.35% |
| Return on Assets (ROA) | 1.92% |
| Return on Invested Capital (ROIC) | 2.24% |
| Return on Capital Employed (ROCE) | 3.58% |
| Revenue Per Employee | $154,691 |
| Profits Per Employee | -$491 |
| Employee Count | 15,000 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, ICU Medical has paid $37.14 million in taxes.
| Income Tax | 37.14M |
| Effective Tax Rate | 124.73% |
Stock Price Statistics
The stock price has decreased by -21.94% in the last 52 weeks. The beta is 0.85, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -21.94% |
| 50-Day Moving Average | 124.98 |
| 200-Day Moving Average | 134.24 |
| Relative Strength Index (RSI) | 67.67 |
| Average Volume (20 Days) | 302,925 |
Short Selling Information
The latest short interest is 1.28 million, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.37M |
| Short % of Shares Out | 5.19% |
| Short % of Float | 5.36% |
| Short Ratio (days to cover) | 4.87 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.32 billion and -$7.36 million in losses. Loss per share was -$0.31.
| Revenue | 2.32B |
| Gross Profit | 846.31M |
| Operating Income | 129.30M |
| Pretax Income | 29.77M |
| Net Income | -7.36M |
| EBITDA | 332.21M |
| EBIT | 129.30M |
| Loss Per Share | -$0.31 |
Full Income StatementBalance Sheet
The company has $303.71 million in cash and $1.38 billion in debt, giving a net cash position of -$1.08 billion or -$43.60 per share.
| Cash & Cash Equivalents | 303.71M |
| Total Debt | 1.38B |
| Net Cash | -1.08B |
| Net Cash Per Share | -$43.60 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 86.17 |
| Working Capital | 714.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $159.44 million and capital expenditures -$87.48 million, giving a free cash flow of $71.96 million.
| Operating Cash Flow | 159.44M |
| Capital Expenditures | -87.48M |
| Free Cash Flow | 71.96M |
| FCF Per Share | $2.92 |
Full Cash Flow StatementMargins
Gross margin is 36.47%, with operating and profit margins of 5.57% and -0.32%.
| Gross Margin | 36.47% |
| Operating Margin | 5.57% |
| Pretax Margin | 1.28% |
| Profit Margin | -0.32% |
| EBITDA Margin | 14.32% |
| EBIT Margin | 5.57% |
| FCF Margin | 3.10% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.20% |
| Shareholder Yield | -1.20% |
| Earnings Yield | -0.21% |
| FCF Yield | 2.08% |
Dividend DetailsAnalyst Forecast
The average price target for ICU Medical is $183.60, which is 31.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $183.60 |
| Price Target Difference | 31.93% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 1.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 7 |
